MX9604047A - Secrecion aumentada de polipeptidos. - Google Patents

Secrecion aumentada de polipeptidos.

Info

Publication number
MX9604047A
MX9604047A MX9604047A MX9604047A MX9604047A MX 9604047 A MX9604047 A MX 9604047A MX 9604047 A MX9604047 A MX 9604047A MX 9604047 A MX9604047 A MX 9604047A MX 9604047 A MX9604047 A MX 9604047A
Authority
MX
Mexico
Prior art keywords
polypeptides
enhanced secretion
sequence
ngf polypeptides
secretion
Prior art date
Application number
MX9604047A
Other languages
English (en)
Inventor
Shi-Yuan Meng
Charles F Morris
Larry B Tsai
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX9604047A publication Critical patent/MX9604047A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporciona una secuencia peptídica de señalizacion y los ácidos nucléicos que codifican esta secuencia, los cuales son utiles para mejorar la eficiencia de la secrecion de los polipéptidos NGF. También se proporciona un método para preparar los polipéptidos NGF sin Met.
MX9604047A 1994-03-18 1995-03-16 Secrecion aumentada de polipeptidos. MX9604047A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/215,138 US5470719A (en) 1994-03-18 1994-03-18 Modified OmpA signal sequence for enhanced secretion of polypeptides
PCT/US1995/003175 WO1995025743A1 (en) 1994-03-18 1995-03-16 Enhanced secretion of polypeptides

Publications (1)

Publication Number Publication Date
MX9604047A true MX9604047A (es) 1997-09-30

Family

ID=22801818

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604047A MX9604047A (es) 1994-03-18 1995-03-16 Secrecion aumentada de polipeptidos.

Country Status (15)

Country Link
US (2) US5470719A (es)
EP (1) EP0750634A1 (es)
JP (1) JPH09510611A (es)
AU (1) AU689569B2 (es)
CA (1) CA2185343A1 (es)
CZ (1) CZ284204B6 (es)
FI (1) FI963655A (es)
HU (1) HUT76674A (es)
IL (1) IL112982A0 (es)
MX (1) MX9604047A (es)
NO (1) NO963818L (es)
NZ (1) NZ283214A (es)
SK (1) SK116896A3 (es)
WO (1) WO1995025743A1 (es)
ZA (1) ZA952218B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747662A (en) * 1995-03-01 1998-05-05 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5888796A (en) * 1996-01-31 1999-03-30 St. Louis University Clone of a nucleotide sequence encoding a protein having two functions
US20020065394A1 (en) * 1998-03-18 2002-05-30 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
KR100360594B1 (ko) * 2000-01-19 2002-11-13 한미약품공업 주식회사 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법
DE60118370T2 (de) 2000-06-05 2006-12-07 Corixa Corp., Seattle Leader-anteile zur erhöhung der sekretion von rekombinanten proteinen aus einer wirtzelle
US20060239966A1 (en) * 2003-10-20 2006-10-26 Tornoee Jens In vivo gene therapy of parkinson's disease
WO2007137300A2 (en) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
US20090280103A1 (en) * 2008-04-04 2009-11-12 Martin Flueck Regulation of muscle repair
WO2010033229A2 (en) * 2008-09-22 2010-03-25 Calmune Corporation Methods and vectors for display of molecules and displayed molecules and collections
JP2012531903A (ja) 2009-07-02 2012-12-13 バーデザイン， インコーポレイテッド アジピン酸を調製する生物学的方法
BRPI1011934A8 (pt) 2009-07-09 2017-10-03 Verdezyne Inc Composição
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US8343752B2 (en) 2011-05-03 2013-01-01 Verdezyne, Inc. Biological methods for preparing adipic acid
US8728798B2 (en) 2011-05-03 2014-05-20 Verdezyne, Inc. Biological methods for preparing adipic acid
MY166952A (en) 2011-07-06 2018-07-25 Verdezyne Inc Biological methods for preparing a fatty dicarboxylic acid
SG10201705057QA (en) 2012-12-19 2017-07-28 Verdezyne Inc Biological methods for preparing a fatty dicarboxylic acid
US9909151B2 (en) 2012-12-19 2018-03-06 Verdezyne, Inc. Biological methods for preparing a fatty dicarboxylic acid
HUE056155T2 (hu) 2014-04-09 2022-01-28 Scripps Research Inst Nem-természetes vagy módosított nukleozid-trifoszfátok sejtekbe importálása nukleinsav-trifoszfát transzporterekkel
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US20180148744A1 (en) 2015-03-20 2018-05-31 Verdezyne, Inc. Biological methods for preparing 3-hydroxypropionic acid
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3652316A4 (en) 2017-07-11 2021-04-07 Synthorx, Inc. INTEGRATION OF NON-NATURAL NUCLEOTIDES AND METHOD FOR THEREFORE
WO2019014309A1 (en) 2017-07-13 2019-01-17 Verdezyne (Abc), Llc BIOLOGICAL METHODS FOR MODIFYING A CELL CARBON FLOW
TWI757528B (zh) 2017-08-03 2022-03-11 美商欣爍克斯公司 用於增生及感染性疾病治療之細胞激素結合物
CN108610398B (zh) * 2018-01-15 2020-08-11 武汉海特生物制药股份有限公司 一段功能序列及在分泌蛋白表达中的应用
WO2020060948A1 (en) 2018-09-17 2020-03-26 Levadura Biotechnology, Inc. Production of cannabinoids in yeast using a fatty acid feedstock
BR112021014415A2 (pt) 2019-02-06 2021-09-21 Synthorx, Inc. Conjugados de il-2 e métodos de uso dos mesmos
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
WO1992005254A1 (en) * 1990-09-25 1992-04-02 Genentech, Inc. Novel neurothrophic factor
WO1993008300A1 (en) * 1991-10-18 1993-04-29 The University Of Calgary Expression-secretion vectors for the production of biologically active fv fragments
JPH07509600A (ja) * 1992-06-12 1995-10-26 リジェネロン　ファーマシューティカルズ，インコーポレーテッド ニューロトロフィン−４発現に基づく治療および診断法
US5474914A (en) * 1992-07-29 1995-12-12 Chiron Corporation Method of producing secreted CMV glycoprotein H

Also Published As

Publication number Publication date
AU2119895A (en) 1995-10-09
EP0750634A1 (en) 1997-01-02
NO963818L (no) 1996-11-15
NO963818D0 (no) 1996-09-12
US5608036A (en) 1997-03-04
HUT76674A (en) 1997-10-28
US5470719A (en) 1995-11-28
AU689569B2 (en) 1998-04-02
NZ283214A (en) 1998-03-25
FI963655A (fi) 1996-11-15
CZ264496A3 (en) 1997-05-14
JPH09510611A (ja) 1997-10-28
CA2185343A1 (en) 1995-09-28
SK116896A3 (en) 1997-08-06
WO1995025743A1 (en) 1995-09-28
HU9602548D0 (en) 1996-11-28
FI963655A0 (fi) 1996-09-16
ZA952218B (en) 1995-12-12
IL112982A0 (en) 1995-06-29
CZ284204B6 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
MX9604047A (es) Secrecion aumentada de polipeptidos.
HUT54177A (en) Process for producing new fluor-containing peptides inhibitors
GB2183661B (en) Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
EP0805857A4 (en) METHOD FOR PRODUCING PROTEOLYTIC ENZYMES WITH SPECIFICITY AGAINST A SELECTED PEPTIDE SEQUENCE
IL81798A0 (en) Method of sequencing peptides
GR871290B (en) Enzymatic membrane method for the synthesis and separation of peptides
AU1884297A (en) Recombinant protein containing a c-terminal fragment of plasmodium msp-1
EP0222412A3 (en) Method of producing peptides
AU7452096A (en) Novel grb2 associating polypeptides and nucleic acids encoding therefor
IL116973A0 (en) Extraction of recombinant proteins
GB9714680D0 (en) Recombinant production of proteins
AU1704988A (en) Peptide production by protein engineering
HU895908D0 (en) Process for producing recombinant interleukin-2 hybrid proteins
HU9403070D0 (en) Improved method for recombinant protein production
NZ304789A (en) Genes encoding lymphocyte interferon regulatory factory (lsirf) polypeptides that are transcription factors and specific antibodies to them
IL94526A0 (en) Method for c-terminal modification of proteins
DE3568298D1 (en) Process for hydrolysis of peptide or protein
CZ135099A3 (cs) Nalfa-2-(4-Nitrofenylsulfonyl)ethoxykarbonylované aminokyseliny
GB9218037D0 (en) Method for enhancing recovery of recombinant proteins
IL139272A0 (en) New peptide fragments for protein purification
GB8806571D0 (en) Supports for proteins & amino acids
GB8511710D0 (en) N-benzyloxycarbonyl amino acids
AU4410689A (en) Method for sequencing peptides or proteins
GB9714681D0 (en) Recombinant production of proteins
IL118112A0 (en) Method for the production of recombinant glucocerobrosidase protein